Patents by Inventor Hualin Simon Xi

Hualin Simon Xi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250122192
    Abstract: The present disclosure relates to compounds of Formula (I); and to their prodrugs, pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds of the present disclosure may act as small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded genes, and methods of use of the compounds for modulating splicing and treating related diseases and conditions. The compounds disclosed herein may possess activity toward various genetic pathways and are accordingly useful in methods of treatment of the human or animal body.
    Type: Application
    Filed: December 2, 2022
    Publication date: April 17, 2025
    Inventors: Travis T. Wager, Zhiping Weng, Hualin Simon Xi
  • Publication number: 20250066389
    Abstract: The present disclosure relates to compounds of Formula (I), and subformulas thereof, and to their pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds of the present disclosure may act as small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded genes, and methods of use of the compounds for modulating splicing and treating related diseases and conditions. The compounds disclosed herein may possess activity toward various genetic pathways and are accordingly useful in methods of treatment of diseases or disorders of the human or animal body.
    Type: Application
    Filed: November 18, 2022
    Publication date: February 27, 2025
    Inventors: Travis T. Wager, Zhiping Weng, Hualin Simon Xi
  • Publication number: 20250042879
    Abstract: The present disclosure relates to compounds of Formula (I); and to their prodrugs, pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds of the present disclosure may act as small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded genes, and methods of use of the compounds for modulating splicing and treating related diseases and conditions. The compounds disclosed herein may possess activity toward various genetic pathways and are accordingly useful in methods of treatment of the human or animal body.
    Type: Application
    Filed: November 22, 2022
    Publication date: February 6, 2025
    Inventors: Travis T. Wager, Zhiping Weng, Hualin Simon Xi
  • Publication number: 20250026753
    Abstract: The present disclosure relates to compounds of Formula (I) or (II) or subformulas thereof: (I) and do their prodrugs, pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds of the present disclosure may act as small molecule splicing modulator that modulate splicing of mRNA, such as pre-mRNA, encoded genes, and methods of use of the compounds for modulating splicing and treating related diseases and conditions. The compounds disclosed herein may possess activity toward various genetic pathways and are accordingly useful in methods of treatment of the human or animal body.
    Type: Application
    Filed: November 11, 2022
    Publication date: January 23, 2025
    Inventors: Travis T. Wager, Zhiping Weng, Hualin Simon Xi